Taysha Gene Therapies, Inc. TSHA Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Acadia PharmaceuticalsACAD

$73.85M+31.2%

Design Therapeutics, Inc.DSGN

$2.73M+27.7%

MeiraGTx Holdings plcMGTX

$12.83M+73.8%

CalAmpCAMP

$2.12M-72.7%

FAQ

What is Taysha Gene Therapies, Inc.'s operating lease liabilities (total)?

Taysha Gene Therapies, Inc. (TSHA) reported operating lease liabilities (total) of $19.32M in Q1 2026.

How has Taysha Gene Therapies, Inc.'s operating lease liabilities (total) changed year-over-year?

Taysha Gene Therapies, Inc.'s operating lease liabilities (total) increased by 4.4% year-over-year, from $18.5M to $19.32M.

What is the long-term trend for Taysha Gene Therapies, Inc.'s operating lease liabilities (total)?

Over 3 years (2022 to 2025), Taysha Gene Therapies, Inc.'s operating lease liabilities (total) has grown at a -3.2% compound annual growth rate (CAGR), from $21.64M to $19.66M.

What does operating lease liabilities (total) mean?

This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.